The systemic hormonal preparations market in Germany, excluding sex hormones and insulins, is showing a steady growth trajectory from 2024 to 2028, with consistent annual increases in per capita spending. From 2024, the forecasted annual growth is approximately 0.93%, with values rising from $21.4 to $22.2 by 2028. The Compound Annual Growth Rate (CAGR) reflects positive market momentum in the upcoming five years.

Future trends to watch for include:

Advancements in hormonal therapy driving new product introductions.
Market dynamics influenced by healthcare policy changes and economic conditions.
Potential shifts in consumer awareness and acceptance of hormonal treatments.